vimarsana.com

Latest Breaking News On - Dose dependent reduction - Page 1 : vimarsana.com

Aeglea BioTherapeutics : Costs Associated with Exit/Disposal - Form 8-K

Aeglea BioTherapeutics Announces Interim Results from Ongoing Phase 1/2 Clinical Trial of Pegtarviliase for the Treatment of Classical Homocystinuria and Begins Process to. | April 12, 2023

United statesMichaelc hanleyKelly bootheCortney caudillLinda neumanAeglea biotherapeuticsJeffrey goldbergExchange commissionEuropean medicines agencyWedbush securities incInvestor relations corporate communicationsAeglea biotherapeutics incCompany annual report on formOngoing phaseClassical homocystinuriaBegins process

Aeglea BioTherapeutics Announces Interim Results from Ongoing Phase 1/2 Clinical Trial of Pegtarviliase for the Treatment of Classical Homocystinuria and Begins Process to Explore Strategic Alternatives

Results from Cohorts 1 and 2 Showed a Dose-Dependent Reduction in Total Homocysteine Levels Results from Cohort 3 Indicated Additional Dose Exploration and Data from Longer Treatment Duration May. | April 12, 2023

United statesLinda neumanAeglea biotherapeuticsJeffrey goldbergCortney caudillMichaelc hanleyAeglea biotherapeutics incExchange commissionWedbush securities incCompany annual report on formEuropean medicines agencyDose dependent reductionTotal homocysteine levelsAdditional dose explorationLonger treatment duration mayPercent change

CinCor Pharma Announces Late-Breaking Presentation of Phase 2 BrigHtn Data on Baxdrostat in Treatment-Resistant Hypertension at the 2022 American Heart Association Scientific Sessions

Aldosterone and renin biomarker activity clinically demonstrate how baxdrostat mechanistically achieves selective blood pressure lowering effects with no impact on cortisol

United statesMason freemanAmerican heart associationCincor pharma incCincor pharmaHeart associationChief medical officerHtn trial highlightsRenin activity reinforceBiological mechanismDose dependent reductionBlood pressure with baxdrostatWell tolerated profile

vimarsana © 2020. All Rights Reserved.